Skip navigation

Lilly beats forecast, cuts costs before Cymbalta fades

(Reuters) - Eli Lilly and Co reported higher-than-expected quarterly earnings on Wednesday as it slashed costs ahead of generic competition later this year for its biggest product, antidepressant Cymbalta, and raised its 2013 profit view on plans for more streamlining. Full story

Feds fine St. Louis drug maker $3.5 million

A St. Louis-based drug maker will pay $3.5 million to settle allegations that it paid doctors to prescribe "outdated, third rate" antidepressants and sleep aids, the U.S. attorney's office in San Francisco announced Thursday. Full story

Some common prescriptions linked to impotence

NEW YORK (Reuters Health) - Tranquilizers known as benzodiazepines and certain older antidepressants are linked with a greater chance of having erectile dysfunction (ED), according to a new survey. Full story

Antidepressants May Help With Heart Disease

For some patients with heart disease, taking antidepressants may reduce the risk of heart problems brought on by mental stress, a new study suggests. Full story

Lundbeck says drug shows improvement in depression symptoms

COPENHAGEN (Reuters) - Danish pharmaceutical group Lundbeck and Japanese partner Takeda said on Saturday that data from clinical phase III studies with the antidepressant vortioxetine had shown significant improvement in patients' symptoms. Full story

Pill nation: Are we too reliant on prescription meds?

   While modern medicines do help us manage pain and live with chronic illnesses, Americans are taking more prescription medication than ever before, leading medical ethicists to ask whether we are taking too many pills for our own good. NBC’s Tom Costello reports.

Sponsored Links


Lundbeck antidepressant gets boost from clinical trial

Antidepressants not tied to stunted infant growth

Along with meds, brain stimulation may aid depression

Mom's Depression Alters Baby Language Learning

Sweets and Fast Food Linked to Depression

Prenatal Exposure to Antidepressants Makes Rats Act Autistic

Making Music Proves to Be Powerful Antidepressant

Widely-used PTSD drug fails test in vets


  GlaxoSmithKline pays $3 billion to settle fraud case

In what is considered the largest case of healthcare fraud in U.S. history, the pharmaceutical giant claimed non-approved uses for various drugs and also failed to give the FDA safety fata about the diabetes drug Avandia. Eventually, GSK agreed to plead guilty to three misdemeanor criminal counts. N